Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Imunon (IMNN)
-
-
-
-
-
-
-
Imunon (IMNN) Finalizes Phase 3 Study Design with FDA for IMNN-001
-
-
-
-
-
-
-
IMUNON (IMNN) Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

